According to the Zhitong Finance App, Hokuriku Pharmaceutical (300016.SZ) issued an announcement. Recently, the company received the “Drug Registration Certificate” for beimoprost eye drops approved and issued by the State Drug Administration. The original research company for bameprost eye drops is Allergan (Allergan) in the United States to reduce intraocular pressure in patients with open-angle glaucoma and ocular hypertension. Bimeprost eye drops have been approved according to the 4 types of chemicals, which is considered to have passed the consistent evaluation of the quality and efficacy of generic drugs, further enriching the company's formulation product pipeline and realizing the product layout in the field of ophthalmology.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.